168 related articles for article (PubMed ID: 9139702)
1. Development of an isotope dilution assay for precise determination of insulin, C-peptide, and proinsulin levels in non-diabetic and type II diabetic individuals with comparison to immunoassay.
Kippen AD; Cerini F; Vadas L; Stöcklin R; Vu L; Offord RE; Rose K
J Biol Chem; 1997 May; 272(19):12513-22. PubMed ID: 9139702
[TBL] [Abstract][Full Text] [Related]
2. [Measurement of proinsulin, insulin and C-peptide in human blood by high performance liquid chromatography].
Povazhenko AA; Ryzhova TI; Kozyreva EV
Klin Lab Diagn; 1997 Sep; (9):34-6. PubMed ID: 9377023
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone-binding protein related immunoreactivity is regulated by the degree of insulinopenia in diabetes mellitus.
Kratzsch J; Keliner K; Zilkens T; Schmidt-Gayk H; Selisko T; Scholz GH
Clin Endocrinol (Oxf); 1996 Jun; 44(6):673-8. PubMed ID: 8759179
[TBL] [Abstract][Full Text] [Related]
4. [The insulin and proinsulin levels in patients with newly detected diabetes mellitus].
Arbuzova MI; Lobanova AM; Smirnova OM; Antsiferov MB; Starostina EG
Probl Endokrinol (Mosk); 1989; 35(5):28-31. PubMed ID: 2685803
[TBL] [Abstract][Full Text] [Related]
5. Abnormal proinsulin/C-peptide ratio in juvenile diabetes.
Ludvigsson J; Heding L
Acta Diabetol Lat; 1982; 19(4):351-8. PubMed ID: 6758459
[TBL] [Abstract][Full Text] [Related]
6. Immunoradiometric assay of insulin, intact proinsulin and 32-33 split proinsulin and radioimmunoassay of insulin in diet-treated type 2 (non-insulin-dependent) diabetic subjects.
Clark PM; Levy JC; Cox L; Burnett M; Turner RC; Hales CN
Diabetologia; 1992 May; 35(5):469-74. PubMed ID: 1521730
[TBL] [Abstract][Full Text] [Related]
7. Parallel changes of proinsulin and islet amyloid polypeptide in glucose intolerance.
MacNamara CM; Barrow BA; Manley SE; Levy JC; Clark A; Turner RC
Diabetes Res Clin Pract; 2000 Oct; 50(2):117-26. PubMed ID: 10960722
[TBL] [Abstract][Full Text] [Related]
8. Neonatal and infant beta cell hormone concentrations in relation to type 1 diabetes risk.
Stumpp C; Beyerlein A; Ziegler AG; Bonifacio E
Pediatr Diabetes; 2014 Nov; 15(7):528-33. PubMed ID: 24552441
[TBL] [Abstract][Full Text] [Related]
9. Do high proinsulin and C-peptide levels play a role in autonomic nervous dysfunction?: Power spectral analysis in patients with non-insulin-dependent diabetes and nondiabetic subjects.
Töyry JP; Niskanen LK; Mäntysaari MJ; Länsimies EA; Haffner SM; Miettinen HJ; Uusitupa MI
Circulation; 1997 Aug; 96(4):1185-91. PubMed ID: 9286948
[TBL] [Abstract][Full Text] [Related]
10. A direct assay for proinsulin in plasma and its applications in hypoglycaemia.
Hampton SM; Beyzavi K; Teale D; Marks V
Clin Endocrinol (Oxf); 1988 Jul; 29(1):9-16. PubMed ID: 3073882
[TBL] [Abstract][Full Text] [Related]
11. Association of serum pancreatic derived factor (PANDER) with beta-cell dysfunction in type 2 diabetes mellitus.
Shehata MM; Kamal MM; El-Hefnawy MH; El-Mesallamy HO
J Diabetes Complications; 2017 Apr; 31(4):748-752. PubMed ID: 28161382
[TBL] [Abstract][Full Text] [Related]
12. A stable isotope dilution assay for the in vivo determination of insulin levels in humans by mass spectrometry.
Stöcklin R; Vu L; Vadas L; Cerini F; Kippen AD; Offord RE; Rose K
Diabetes; 1997 Jan; 46(1):44-50. PubMed ID: 8971080
[TBL] [Abstract][Full Text] [Related]
13. [The occurrence of proinsulin and C-peptide in healthy humans and in diabetics].
Beischer W
Fortschr Med; 1982 Sep; 100(33):1508-12. PubMed ID: 7129312
[TBL] [Abstract][Full Text] [Related]
14. Serum Vitamin D and Its Upregulated Protein, Thioredoxin Interacting Protein, Are Associated With Beta-Cell Dysfunction in Adult Patients With Type 1 and Type 2 Diabetes.
Omar DF; Kamal MM; El-Hefnawy MH; El-Mesallamy HO
Can J Diabetes; 2018 Dec; 42(6):588-594. PubMed ID: 29980378
[TBL] [Abstract][Full Text] [Related]
15. Determination of free and total insulin and C-peptide in insulin-treated diabetics.
Kuzuya H; Blix PM; Horwitz DL; Steiner DF; Rubenstein AH
Diabetes; 1977 Jan; 26(1):22-9. PubMed ID: 830562
[TBL] [Abstract][Full Text] [Related]
16. Proinsulin level in diabetes mellitus measured by a new immunochemiluminometric assay.
Wu TJ; Lin CL; Taylor RL; Kao PC
Ann Clin Lab Sci; 1995; 25(6):467-74. PubMed ID: 8572555
[TBL] [Abstract][Full Text] [Related]
17. Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance.
Reaven GM; Chen YD; Hollenbeck CB; Sheu WH; Ostrega D; Polonsky KS
J Clin Endocrinol Metab; 1993 Jan; 76(1):44-8. PubMed ID: 8421101
[TBL] [Abstract][Full Text] [Related]
18. Elevated fasting pro-insulin levels as a marker for impaired function after pancreas transplantation.
Weide LG; Stratta RJ; Cushing K; Groggel G
Transplant Proc; 1997; 29(1-2):678. PubMed ID: 9123477
[No Abstract] [Full Text] [Related]
19. Prediction of Impending Type 1 Diabetes through Automated Dual-Label Measurement of Proinsulin:C-Peptide Ratio.
Van Dalem A; Demeester S; Balti EV; Keymeulen B; Gillard P; Lapauw B; De Block C; Abrams P; Weber E; Vermeulen I; De Pauw P; Pipeleers D; Weets I; Gorus FK;
PLoS One; 2016; 11(12):e0166702. PubMed ID: 27907006
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.
Jehle PM; Jehle DR; Mohan S; Böhm BO
J Endocrinol; 1998 Nov; 159(2):297-306. PubMed ID: 9795371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
